Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137

Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137
Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced that a multi-center, Phase 1, single agent, dose escalation trial evaluating intravenous administration of … Read more on Lifescience-online

State prisons could do without burden of so many drug offenders
Perhaps we might be more successful by mandating intensive inpatient treatment for drug abusers, including long term after-care. Perhaps we should invest more money to educating children and treating the addicted. Of course, this is my opinion, I could … Read more on Norman Transcript

Implanted Device Controls Rheumatoid Arthritis
An electrical device that stimulates the vagus nerve is already used to treat some cases of drug-resistant epilepsy and depression, and another is undergoing testing as a treatment for congestive heart failure. But SetPoint is covering new ground by … Read more on MIT Technology Review